Integral Health Asset Management’s NEVRO CORP. NVRO Stock Holding History

Integral Health Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-109,000	Closed	-$4.32M	–	92
2022 Q4	$4.32M	Buy	109,000 +9,000	+9%	+$374K	0.91%	42
2022 Q3	$4.66M	Buy	100,000 +21,723	+28%	+$1.01M	0.91%	44
2022 Q2	$3.43M	Buy	78,277 +28,277	+57%	+$1.55M	0.71%	46
2022 Q1	$3.62M	Buy	50,000 +15,000	+43%	+$1.08M	0.94%	38
2021 Q4	$2.84M	Buy	35,000 +5,000	+17%	+$501K	0.79%	41
2021 Q3	$3.49M	Sell	30,000 -8,000	-21%	-$1.05M	1%	44
2021 Q2	$6.3M	Sell	38,000 -2,000	-5%	-$312K	1.73%	23
2021 Q1	$5.58M	Sell	40,000 -48,000	-55%	-$7.83M	1.59%	23
2020 Q4	$15.2M	Buy	88,000 +20,000	+29%	+$3.24M	4.53%	4
2020 Q3	$9.47M	Sell	68,000 -7,000	-9%	-$935K	2.9%	10
2020 Q2	$8.96M	Buy	75,000 +35,000	+88%	+$4.15M	2.68%	9
2020 Q1	$4M	Buy	+40,000	New	+$4.81M	1.76%	22

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Integral Health Asset Management's NVRO Position: Q1 2023 in Review

Integral Health Asset Management sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 109,000 shares — an estimated $4.32M sold.

Integral Health Asset Management first reported a position in NVRO in Q1 2020 and held it in 12 quarters. The position peaked at $15.2M in Q4 2020. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

Integral Health Asset Management reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
Integral Health Asset Management sold 109,000 NEVRO CORP. shares in Q1 2023, an estimated $4.32M.
Integral Health Asset Management first reported a position in NEVRO CORP. in Q1 2020 and held it in 12 quarters.
Integral Health Asset Management's NEVRO CORP. position peaked at $15.2M in Q4 2020.
158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Integral Health Asset Management's 13F filing for Q1 2023, filed 9 May 2023.